PCM TRIALS - Quality Mobile Research

What’s next for community-based research? We want to hear from you! ??? We are exploring industry perspectives on patient optionality and how mobile and community-based models are shaping the future of research. Your insights can help drive meaningful change in trials. Interested in sharing your thoughts? Take the survey here: https://hubs.ly/Q03cLlfg0 (takes about 5-7 minutes to complete) #ClinicalResearch #PatientOptionality #CommunityBasedResearch #IndustrySurvey PCM TRIALS - Quality Mobile Research

How do community-based research sites expand access to trials while ensuring consistency in study protocols? Mark McKenzie, M.D. explains that community-based sites make research more accessible by bringing trials directly to patients in local communities, all while maintaining rigorous trial standards. By mirroring the processes of larger academic centers, EmVenio Research ensures reliable data collection and consistent patient interactions. Interested in learning more? We debunk five common misconceptions about community-based research sites here: https://hubs.ly/Q03cL7BW0 #CommunityEngagement #PatientCentricity #ClinicalResearch

We're excited to meet up with our European research community at DIA EU 2025. Stop by to meet Jeff Huntsman, Brandon Wall, MHA, Rachael Sawaya, MPH, and Beate ten Bokum and learn more about the ways we're reaching and retaining more patients in clinical trials around the world #CommuityResearch #InnovationInHealthcare #PatientAccess #GlobalReach

We are heading to #DIAEU, March 18-20 in Basel, Switzerland! Find Jeff Huntsman, Brandon Wall, MHA, Rachael Sawaya, MPH, and Beate ten Bokum at booth #G7 to learn how community-based research solutions extend trial reach to boost patient inclusivity, increase patient retention, and improve overall study outcomes. See you there! #CommunityResearch #HealthEquity #CommunityBasedTrials

Every patient deserves a path to treatment. On #RareDiseaseDay, we’re shining a light on the millions of people living with rare diseases and the urgent need for continued research. There are currently more than 7,000 known rare diseases…and less than 5% have an effective treatment. For many of those facing rare diseases, traditional trial models aren’t an option. Patient-centric approaches, like mobile visits and community-based solutions, are critical to making research possible. At PCM Trials, we’re passionate about supporting rare disease communities. We’ve supported hundreds of rare disease protocols, bringing research directly to patients to ease the burden of participation and improve access, retention, and data quality. Learn more about how community-based research models help support the advancement of rare disease research here: https://hubs.ly/Q038FSLp0 #PatientCentricity #CommunityResearch #RareDisease

Access is everything in clinical research. While decentralized clinical trials saw a major surge during the pandemic, the data still shows a lasting impact: When decentralized and community-based options are available, more women, African Americans, Native Americans, and single parents enroll in trials. In this clip, Tajuana Barron, VP of Project Management at PCM Trials, explains how flexible participation options bridge access gaps and expand trial reach for historically underrepresented groups. Interested in learning more? Check out this article for a deeper dive into where today’s trials are still missing the mark on patient access: https://hubs.ly/Q037g7y40 #CommunityResearch #AccessForAll #ClinicalTrials

Today on #InternationalAngelmanDay, we honor the incredible strength and resilience of the individuals and families affected by Angelman syndrome. With an estimated 500,000 people worldwide affected by this rare neurological disorder, the need for clinical research has never been greater. We’re proud to play a role in making clinical research more accessible, helping bring potential new treatments closer to the patients and families who need them most. #AngelmanSyndrome #RareDisease #ClinicalReseach

What a fantastic start to #OCTWestCoast! In case you missed it, Stephanie Hitchcock gave a great presentation on how sponsors can translate regulatory guidance into actionable strategies for more inclusive research. Stop by booth #44 to chat with Stephanie, Tracy, and Jamal and learn how our community-based research solutions support equitable access in clinical trials. We can’t wait to meet you! #CommunityResearch #AccessForAll

We’re heading to OCT West Coast in San Francisco, CA on February 11-12! Catch up with Tracy Rasoul and Jeff Huntsman at booth #44 to hear more about how we are extending the reach of clinical trials with our community-based research model to improve patient accessibility while meeting study goals. Join us to hear from Stephanie Hitchcock, Director of Project Management in Global Clinical Trials, as she discusses the evolving landscape of diversity and inclusivity in clinical trials, global requirements, and industry trends in the following presentation:? From Guidance to Action: Navigating Inclusivity in Clinical Trials? ??Date: February 11? ??Time: 11:30 am? See you there!?? #CommunityResearch #AccessForAll #InclusivityInTrials #OCTWestCoast

Kicking off the day at #SCOPE2025 with great discussions and new connections! Stop by booth #1428 to receive a free health check from one of our attending providers, meet our team, and learn more about how community-based research solutions can extend the reach of clinical trials. #CommunityResearch #PatientAccess #ClinicalTrials